Remember
 

$AMAG AMAG Pharma completed sale of rights to Intrarosa to Millicent Pharma for up to $125M, including $20M upfront consideration and up to $105M in contingent sales-based milestones.”


 More than 1 mo ago by corporatealerts  •  Posted on Friday, May 22nd at 3:04 PM MST  •  0 REACTIONS

 Do You Know the Most Important and Timely Stock Plays During the Trading Week? View Our Power Rankings.
React to the Post Above with Your Unique Insight
 

Global Streams

 
PulseStream
SpecStream
UserStream
Reactions
EchoStream